Historical record - last NADAC effective date: 8/18/2021

Product Information

OLOPATADINE HCL 0.2% EYE DROP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $4.2477 per ML under NDC 62332050203. Its NADAC has been published 71 times since Apr 29, 2020.

FDA first approved this application on Apr 29, 2019.

OLOPATADINE HCL 0.2% EYE DROP

olopatadine hydrochloride
$4.2477per ML

Strength

2 mg/mL

NDC

62332050203

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

8/18/2021

Active Ingredients

OLOPATADINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA209420

FDA Approved

4/29/2019

On Market Since

4/29/2019

Pharmacological Classes

Decreased Histamine Release
Histamine H1 Receptor Antagonists
Histamine-1 Receptor Inhibitor

Price Statistics

The NADAC for OLOPATADINE HCL 0.2% EYE DROP has been published 71 times since Apr 29, 2020, and over the history we have for it it has declined 26.8%. The table below summarizes its recorded NADAC range and movement.

Current price$4.2477 per ML
All-time high$5.8621 (Jul 14, 2021)
All-time low$4.2477 (Aug 18, 2021)
Median price$5.0379
Average price$5.0475
Largest weekly change-26.6% (Jul 21, 2021)
Weeks tracked71
Tracking sinceApr 29, 2020

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

0.0%

All

-26.8%

Last surveyed Sep 1, 2021 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the olopatadine hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of OLOPATADINE HCL 0.2% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for OLOPATADINE HCL 0.2% EYE DROP, manufactured by Alembic Pharmaceuticals Inc., is $4.2477 per ML (NDC 62332050203), effective Sep 1, 2021.

How has the price of OLOPATADINE HCL 0.2% EYE DROP changed over time?

Over the history we have for it, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has declined 26.8%. It has been tracked across 71 weekly CMS publications since Apr 29, 2020.

What are the highest and lowest recorded NADAC prices for OLOPATADINE HCL 0.2% EYE DROP?

Since Apr 29, 2020, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has ranged from a low of $4.2477 (Aug 18, 2021) to a high of $5.8621 (Jul 14, 2021), with a median of $5.0379 per ML.

Are there cheaper alternatives to OLOPATADINE HCL 0.2% EYE DROP?

No other NADAC-published product currently shares the active ingredient and strength of OLOPATADINE HCL 0.2% EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures OLOPATADINE HCL 0.2% EYE DROP?

OLOPATADINE HCL 0.2% EYE DROP (NDC 62332050203) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.